Chromosomal Heterogeneity of the G-401 Rhabdoid Tumor Cell Line: Unusual Partial 7p Trisomy

Fasler-Kan, Elizaveta; Aliu, Nijas; Haecker, Frank-Martin; Maltsev, Natalia; Ruggiero, Sabrina; Cholewa, Dietmar; Bartenstein, Andreas; Milosevic, Milan; Berger, Steffen M. (2019). Chromosomal Heterogeneity of the G-401 Rhabdoid Tumor Cell Line: Unusual Partial 7p Trisomy. Frontiers in medicine, 6, p. 187. Frontiers 10.3389/fmed.2019.00187

[img]
Preview
Text
fmed-06-00187.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

Rhabdoid tumor is a very aggressive and hardly curable pediatric malignancy. It commonly starts in the kidneys but also can occur in the brain, liver, and other organs. The treatment of this tumor usually involves a combination of surgery, radiation, and chemotherapy. Because this tumor is rare, there is still limited experience with a defined standard of care. Cytogenetic analysis is an important routine method to monitor chromosomal aberrations. We have analyzed metaphases of the G-401 rhabdoid tumor cell line. In these cells we have observed metaphases with derivative chromosome 12 arising from partial trisomy 7p. With increasing passage number the numbers of metaphases having this derivative chromosome 12 were found to be higher. In passage number 2 only one metaphase had this pathological chromosome 12. By passage number 10 and passage number 15 about 25 and 95% of this derivative chromosome 12 were found, respectively. We were able to subclone G-401 cells by limiting dilutions and successfully separated cells having apparently normal karyotypes from cells having derivative chromosome 12. Using the cell proliferation assay we showed that clones possessing the derivative chromosome 12 grew more rapidly than clones with normal chromosomes. The cell cycle analysis confirmed this observation. Overall, in this study we describe for the first time a 7p triplication in a rare rhabdoid tumor of kidney. Both types of clones described in this study could be used as a preclinical model to study the involvement of partial chromosome 7 alterations in the development of rhabdoid tumors.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Research Group Pediatric Surgery
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Surgery

UniBE Contributor:

Fasler-Kan, Elizaveta; Ruggiero, Sabrina; Cholewa, Dietmar; Bartenstein, Andreas; Milosevic, Milan and Berger, Steffen Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2296-858X

Publisher:

Frontiers

Language:

English

Submitter:

Christoph Steffen

Date Deposited:

05 Dec 2019 15:42

Last Modified:

08 Dec 2019 02:46

Publisher DOI:

10.3389/fmed.2019.00187

PubMed ID:

31544104

BORIS DOI:

10.7892/boris.135426

URI:

https://boris.unibe.ch/id/eprint/135426

Actions (login required)

Edit item Edit item
Provide Feedback